These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 1526691)

  • 41. A practical approach for comparing means of two groups without equal variance assumption.
    Wang H; Chow SC
    Stat Med; 2002 Oct; 21(20):3137-51. PubMed ID: 12369087
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An alternative to the use of two-sided tests in clinical trials.
    Dunnett CW; Gent M
    Stat Med; 1996 Aug; 15(16):1729-38. PubMed ID: 8870155
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sample size considerations for assessing individual bioequivalence based on the method of tolerance intervals.
    Esinhart JD; Chinchilli VM
    Int J Clin Pharmacol Ther; 1994 Jan; 32(1):26-32. PubMed ID: 8199749
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Power of the two one-sided tests procedure in bioequivalence.
    Phillips KF
    J Pharmacokinet Biopharm; 1990 Apr; 18(2):137-44. PubMed ID: 2348380
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sample size calculation for the Power Model for dose proportionality studies.
    Sethuraman VS; Leonov S; Squassante L; Mitchell TR; Hale MD
    Pharm Stat; 2007; 6(1):35-41. PubMed ID: 17323313
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Experimental design and statistical methods for classical and bioequivalence hypothesis testing with an application to dairy nutrition studies.
    Tempelman RJ
    J Anim Sci; 2004; 82 E-Suppl():E162-172. PubMed ID: 15471796
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sample size determination for equivalence assessment with multiple endpoints.
    Sun A; Dong X; Tsong Y
    J Biopharm Stat; 2014; 24(6):1203-14. PubMed ID: 25032845
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sample size determination for proving equivalence based on the ratio of two means for normally distributed data.
    Hauschke D; Kieser M; Diletti E; Burke M
    Stat Med; 1999 Jan; 18(1):93-105. PubMed ID: 9990695
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Consideration of individual bioequivalence.
    Anderson S; Hauck WW
    J Pharmacokinet Biopharm; 1990 Jun; 18(3):259-73. PubMed ID: 2380920
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sample size determination for a three-arm equivalence trial of normally distributed responses.
    Chang YW; Tsong Y; Dong X; Zhao Z
    J Biopharm Stat; 2014; 24(6):1190-202. PubMed ID: 25098678
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Testing bioequivalence for multiple formulations with power and sample size calculations.
    Zheng C; Wang J; Zhao L
    Pharm Stat; 2012; 11(4):334-41. PubMed ID: 22692852
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The empirical coverage of confidence intervals: point estimates and confidence intervals for confidence levels.
    Schall R
    Biom J; 2012 Jul; 54(4):537-51. PubMed ID: 22623325
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Determining equivalence and the impact of sample size in anti-infective studies: a point to consider.
    Bristol DR
    J Biopharm Stat; 1996 Jul; 6(3):319-26. PubMed ID: 8854235
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sample size determination for the two one-sided tests procedure in bioequivalence.
    Liu JP; Chow SC
    J Pharmacokinet Biopharm; 1992 Feb; 20(1):101-4. PubMed ID: 1588502
    [No Abstract]   [Full Text] [Related]  

  • 55. An approximate approach to sampling size determination for the equivalence hypothesis.
    Hsieh CY; Liu JP
    J Biopharm Stat; 2013 May; 23(3):526-38. PubMed ID: 23611193
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Elements of significance testing with equivalence problems.
    Wellek S; Michaelis J
    Methods Inf Med; 1991 Aug; 30(3):194-8. PubMed ID: 1943791
    [TBL] [Abstract][Full Text] [Related]  

  • 57. On the use of the ratio or the odds ratio of cure rates in therapeutic equivalence clinical trials with binary endpoints.
    Tu D
    J Biopharm Stat; 1998 May; 8(2):263-82. PubMed ID: 9598422
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A note on statistical methods for assessing therapeutic equivalence.
    Chow SC; Shao J
    Control Clin Trials; 2002 Oct; 23(5):515-20. PubMed ID: 12392865
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An approach for sample size determination of average bioequivalence based on interval estimation.
    Chiang C; Hsiao CF
    Stat Med; 2017 Mar; 36(7):1068-1082. PubMed ID: 28070984
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of parametric and nonparametric two one-sided tests procedures for assessing bioequivalence of average bioavailability.
    Liu JP; Weng CS
    J Biopharm Stat; 1993 Mar; 3(1):85-102. PubMed ID: 8485538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.